Discovery of possible biomarker of migraine
A long time search may have come to an end: scientists have found that measuring adiponectin (ADP) before and after migraine treatment can accurately reveal which headache victims felt pain relief. According to study leader B. Lee Peterlin, this study 'takes the first steps in identifying a potential biomarker for migraine that predicts treatment response and, we hope, can one day be used as a target for developing new and better migraine therapies.' A report on the study of people experiencing 2 to 12 migraine headaches per month, led by researchers at Johns Hopkins, is published in the March issue of the journal Headache. Continue reading
